Johnson & Johnson (NYSE:JNJ) Position Reduced by Pavion Blue Capital LLC

Pavion Blue Capital LLC decreased its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 0.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 32,690 shares of the company’s stock after selling 124 shares during the quarter. Johnson & Johnson makes up 2.8% […]

Related Keywords

Canada ,Dekabank Deutsche Girozentrale ,Raymond James ,Jenniferl Taubert ,Cantor Fitzgerald ,Johnson ,Securities Exchange Commission ,Capital Management Associates Inc ,Royal Bank ,Tritonpoint Wealth ,Exchange Commission ,Morgan Stanley ,Joel Isaacson Co ,Pavion Blue Capital ,Free Report ,Blue Capital ,Capital Management ,Management Associates Inc ,Bank Deutsche Girozentrale ,Johnson Trading Down ,Get Free Report ,Innovative Medicine ,Johnson Daily ,